ICUI MEXC RealStocks
Own real ICUI shares through MEXC's regulated brokerage partner.
Suitable for long-term holding.
- Own the actual shares
- Receive dividends and voting rights
- Buy fractional shares starting at $1
Last updated: 2026-11-19 05:49:00. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
ICU Medical Inc. (ICUI) operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector and is listed on NASDAQ. The stock is currently priced at $178.56, with a market capitalization of $4.55B and a P/E ratio of 73.34. Over the past 52 weeks, its price has ranged from $113.37 to $192.85. This page covers its latest market performance, valuation, price trends and company information.
$4.55B | |
$175.22 | |
$179.74 | |
$171.07 | |
$176.91 | |
181.06K | |
254.53K | |
73.34 | |
$192.85 | |
$113.37 | |
-- | |
2026-09-30 |
ICU Medical Inc. (ICUI) last closed at $178.56 as of 2026-11-18 21:21:00, up 0.97% ($1.71) from the previous close of $176.91.
During the latest regular trading session, ICUI traded between $171.07 and $179.74, with a volume of 181.06K shares. The closing price was near the upper end and near the upper end of its 52-week range.
Over the past seven days, ICU Medical Inc. (ICUI) moved from $178.85 to $178.56, representing a decline of 0.16% ($0.29).
The stock traded between $171.07 and $183.88 during the period. The latest price is near the middle of the 7-day range, indicating range-bound.
The average daily volume was 293.80 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 82.0%
ICUI is currently trading at $178.56, placing it 82.0% of the way from its 52-week low of $113.37 to its 52-week high of $192.85. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (50% of consolidated revenue), infusion systems (30%), and vital care (20%). The combined entity remains primarily US-focused, generating over 60% of its sales domestically.
| Industry | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
| Employees | 13,000 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of ICU Medical Inc. (ICUI) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to ICUI, including Stocks, Tokenized Stocks, and Stock Futures.
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Estimate the value between ICUI shares and USD.
ICUI Shares to USD
1.00 ICUI shares = 178.564 USD
Calculations are estimates based on the latest available price and are for reference only.